FOLFOX
Showing 26 - 50 of 888
Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, Pembrolizumab)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- CYAD-101
- +2 more
-
Jacksonville, Florida
- +4 more
Feb 22, 2022
Metastatic Pancreatic Cancer Trial in Seoul (TEW-7197)
Recruiting
- Metastatic Pancreatic Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Colorectal Cancer, Pancreatic Cancer, Gastric Cancers Trial in Canada, Korea, Republic of, United States (BOLD-100 in
Recruiting
- Colorectal Cancer
- +3 more
- BOLD-100 in combination with FOLFOX Chemotherapy
-
Santa Monica, California
- +12 more
Aug 18, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX Trial in Kaunas (Radiotherapy 50 Gy, Fluorouracil/folic acid,
Recruiting
- Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
- Radiotherapy 50 Gy
- +2 more
-
Kaunas, LithuaniaRita Ambraziene
May 12, 2022
Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)
Not yet recruiting
- Hepatocellular Carcinoma
- HAIC(FOLFOX)
- +5 more
- (no location specified)
Aug 16, 2022
Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)
Not yet recruiting
- Gastric Cancer
- +4 more
- CA-4948
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 27, 2022
Locally Advanced Pancreatic Cancer, Pancreatic Cancer Trial in Providence (FOLFOXA)
Active, not recruiting
- Locally Advanced Pancreatic Cancer
- Pancreatic Cancer
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Feb 23, 2022
Neurotoxicity in Gastrointestinal Cancer Patients Receiving
Recruiting
- Gastrointestinal Cancer
- Folfox Protocol
-
Cairo, Abassia, EgyptAin shams university
Aug 8, 2022
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)
Completed
- Metastatic Colorectal Cancer
- FOLFOXIRI Protocol
-
Cairo, El Manial, EgyptKasr El AiniH
Mar 30, 2022
Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))
Recruiting
- Rectal Cancer
- mFOLFOX (neoadjuvant)
- +6 more
-
Mannheim, GermanyUnversity Hospital Mannheim
Aug 12, 2022
Advanced Hepatocellular Carcinoma Trial in Nanjing (SHR-1210, FOLFOX4, Placebo)
Recruiting
- Advanced Hepatocellular Carcinoma
- SHR-1210
- +2 more
-
Nanjing, Jiangsu, China81 Hospital Nanjing
Feb 9, 2022
Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)
Not yet recruiting
- Metastatic Colorectal Carcinoma
- Pentoxifylline
- +3 more
- (no location specified)
Nov 1, 2023
Rectal Adenocarcinoma Trial in Baltimore (FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}, Low dose fractionated
Terminated
- Rectal Adenocarcinoma
- FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
- Low dose fractionated radiation therapy (LDFRT)
-
Baltimore, MarylandUmmc Msgcc
Oct 6, 2021
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)
Active, not recruiting
- Adenocarcinoma of the Stomach
- GastroEsophageal Cancer
- Nivolumab
- +3 more
-
Amberg, Germany
- +26 more
Jan 12, 2023
Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)
Recruiting
- Gastric Cancer
- Taurine
- +4 more
-
Xi'an, Shaanxi, ChinaTang-Du Hospital
Nov 2, 2023
/or PD-1 Inhibitors for Unresectable Intrahepatic
Completed
- Intrahepatic Cholangiocarcinoma
- hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 7, 2022
Metastatic Pancreatic Cancer Trial in Fairhaven, Providence (FOLFOXA)
Completed
- Metastatic Pancreatic Cancer
-
Fairhaven, Massachusetts
- +1 more
Jul 27, 2022
Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85
Active, not recruiting
- Gastro-Esophageal Junction Adenocarcinoma
- Gastric Cancer
- Nab-paclitaxel 150 mg/m^2
- +3 more
-
Chicago, Illinois
- +7 more
Feb 16, 2022
Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)
Recruiting
- Hepatocellular Carcinoma
- HAIC
- Zoledronic acid
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
May 10, 2023
Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B
Recruiting
- Colorectal Cancer
- +5 more
- Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
- Repeat local treatment
-
Amsterdam, NetherlandsAmsterdam UMC
May 5, 2023
Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)
Recruiting
- Colo-rectal Cancer
- Experimental: mXELOX plus cetuximab
- Active Comparator: FOLFOX plus cetuximab
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023